首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of liver cancer

缩写:

ISSN:2288-8128

e-ISSN:2383-5001

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引188
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yi De Ian Koh,Wei-Qiang Leow Yi De Ian Koh
Hepatic tuberculosis (HTB) is an uncommon manifestation of tuberculous infections, and there has been no proven causal link between HTB and hepatocellular carcinoma (HCC). We herein present a rare case of a synchronous presentation of HTB a...
Nalee Kim,Jeong Il Yu,Hee Chul Park et al. Nalee Kim et al.
Background/aim: Patients with large (>5 cm) hepatocellular carcinoma (HCC) have limited treatment options, thus necessitating the identification of prognostic factors and the development of predictive tools. This study ai...
Matthew Man Pok Lee,Landon Long Chan,Stephen Lam Chan Matthew Man Pok Lee
Hepatocellular carcinoma (HCC) frequently presents as advanced stage with poor prognosis and high mortality. Systemic treatment is the treatment of choice for advanced disease. In 2007, the first multi-kinase inhibitor (MKI) sorafenib was a...
Roopali Sehrawat,Nalini Bansal,Ajitabh Srivastava et al. Roopali Sehrawat et al.
Basidiobolus ranarum is known to cause subcutaneous mycoses; however, rare cases of hepatic and gastrointestinal involvement by basidiobolomycosis have been reported. Hepatic basidiobolomycosis may be confused with a carcinoma on imaging, a...
Tae Hyun Kim,Bo Hyun Kim,Yu Ri Cho et al. Tae Hyun Kim et al.
Background/aim: Radiotherapy (RT) is an effective local treatment for hepatocellular carcinoma (HCC). However, whether additional RT is safe and effective in patients with advanced HCC receiving atezolizumab plus bevacizu...
Kyoungdo Mun,Jiwon Han,Pureun Roh et al. Kyoungdo Mun et al.
Background/aim: Cancer-associated fibroblasts (CAFs) play an immunosuppressive role in the tumor microenvironment (TME) of human cancers; however, their characteristics and role in hepatocellular carcinoma (HCC) remain to...
Yuri Cho,Jin Woo Choi,Hoon Kwon et al. Yuri Cho et al.
Transarterial chemoembolization (TACE) was introduced in 1977 with the administration of chemotherapeutic agent to gelatin sponge particles through the hepatic artery in patients with hepatocellular carcinoma (HCC) and was established as co...
Hyung-Woo Lee,Gi-Ae Kim,Chi Hyuk Oh et al. Hyung-Woo Lee et al.
Optimal treatments for patients with advanced hepatocellular carcinoma (HCC) are still limited and their prognosis remains dismal. Yet, there have been rare cases that have shed light on longer survival in these patients assisted by various...
Pil Soo Sung,Sung Woo Cho,Jaejun Lee et al. Pil Soo Sung et al.
Background/aims: Lenvatinib was recently proven to be non-inferior to sorafenib in treating unresectable hepatocellular carcinoma (HCC) in a phase-3 randomized controlled trial. In this study, we investigated whether the ...